EC proposes manufacturing waiver for export of generics, biosimilars

The European Commission proposed an amendment to its IP rules that will allow EU companies to manufacture generic or

Read the full 194 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE